she took a glp-1 and lost her taste for pleasure Weight-loss drugs could spell the end of food as Stopping GLP-1s: Weight Regain and

Description

Prevalence of eating disorder The systematic analysis of the selected studies indicates that about 8% of respondents have eating disorders and 3% experience recurrent episodes

Whilst the medicolegal responsibility for the GLP-1 rests with the prescriber, once we know that the patient is taking it, we would be liable if we continued to prescribe other medicines that interact, without taking that into account

Advertised Pricing Accuracy Mionor issues Meta ads promote only the lowest monthly option from the largest bundle without disclosing the bundle requirement

International AEM Malta Edward John Despott UOM Georgios Kalopitas Alberto Murino Fujifilm Healthcare Europe European Society of Gastrointestinal Endoscopy (ESGE) UEG - United European Gastroenterology American Society for Gastrointestinal Endoscopy (ASGE) Endoscopy on Air Foundation for Interventional & Therapeutic Endoscopy Erbe Group American College of Gastroenterology To view or add a comment, sign in Sphenopalatine Ganglion Radiofrequency Ablation for Craniofacial Pain: A Comprehensive Review of Anatomy, Procedural Technique, Clinical Evidence, and Interdisciplinary Implications --- --- Dr Indunil Karunarathna Uva Clinical Research Lab 2026 Uva Clinical Anaesthesia and Intensive Care ISSN 2827-7198, 2026 The sphenopalatine ganglion (SPG) DOI:10.5281/zenodo.20271746 , also known as the pterygopalatine ganglion, is a major extracranial parasympathetic hub with critical roles in trigeminal autonomic cephalalgias (TACs) and other refractory craniofacial pain syndromes